GFI #256 - Impacts on Drug Compounding

What is GFI #256?

  • Guidance for Industry 256
  • FDA’s approach to situations where DVMs need access to drugs compounded from hospital stock when no-FDA approved drug can be used
  • Plan ahead! Starts April 1, 2023

Resources

-Covetrus rep for more information

https://www.fda.gov/media/132567/download

Webinar on GFI 256 is linked HERE.

More information on GFI #256, including the list of approved drugs, is HERE.

Direct link to table of approved drugs: https://www.fda.gov/animal-veterinary/animal-drug-compounding/list-bulk-drug-substances-compounding-office-stock-drugs-use-nonfood-producing-animals